Stock Market & Financial News
Ecolab (ECL) Earnings Expected to Grow: Should You Buy?
Ecolab (ECL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ECL Corning (GLW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Corning (GLW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GLW Expand Energy (EXE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Expand Energy (EXE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EXE GSK (GSK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GSK 
Herc Holdings (HRI) Expected to Beat Earnings Estimates: Should You Buy?
Herc Holdings (HRI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HRI 
IQVIA Holdings (IQV) Reports Next Week: Wall Street Expects Earnings Growth
IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IQV 
Hilton Worldwide Holdings Inc. (HLT) Reports Next Week: Wall Street Expects Earnings Growth
Hilton Worldwide (HLT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HLT 
Johnson & Johnson vs Abbott Laboratories: Two Healthcare Giants on Opposite Trajectories
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) and Abbott Laboratories (NYSE:ABT) both recently posted earnings that show two healthcare giants moving in opposite strategic directions.
ABT 
Ondo Finance up 14% as entity buys $61M ONDO – Is more upside coming?
Large entities are accumulating ONDO tokens, but can the daily candle close above $0.40?
SCHD just hit a crucial milestone: is it a good dividend ETF to buy?
The Schwab US Dividend Equity ETF (SCHD) has reached a major milestone this year, driven by robust investor inflows and solid market performance. The fund recently surpassed $100 billion in assets under management (AUM), making it the second-largest dividend ETF behind the Vanguard Dividend Appreciation ETF (VIG).
SCHD 
Silver Price Forecast: XAG/USD surges as Middle East tensions boost safe-haven demand
Silver Price Forecast: XAG/USD surges as Middle East tensions boost safe-haven demand
Ocado to build robotic warehouse for unnamed European retailer
Britain's Ocado said on Tuesday it would build a large robotic warehouse for a fast-growing European national retailer that it did not name, providing a boost to its embattled technology solutions business.
OCDDY 
Comfort Systems USA: Capacity Is The Advantage
Comfort Systems USA (FIX) is rated Buy, driven by its unmatched scale, integrated capabilities, and strong balance sheet supporting data center and tech facility demand. FIX's $12.45B backlog, up 80.8% y/y, provides high revenue visibility, with 65–75% of obligations expected to convert within 12 months. Q1 2026 EBIT margin expanded to 17% (15.5% normalized), reflecting operating leverage and higher-margin backlog conversion.
FIX 
Halliburton tops Q2 earnings estimates as CEO warns of softer oilfield services market
Halliburton Company (NYSE:HAL, XETRA:HAL) reported second quarter results that exceeded Wall Street expectations, but shares fell more than 6% after management warned that the oilfield services market is weakening more than previously anticipated in the short to medium term. The oilfield services company posted adjusted earnings of $0.55 per share, ahead of the consensus estimate of $0.54.
HAL 
3M stock jumps 10% after earnings beat, raised annual profit outlook
3M MMM shares rallied about 10% on Tuesday after the industrial conglomerate reported better-than-expected second-quarter earnings and raised its full-year profit forecast, citing pricing actions, cost reductions and resilient demand across key industrial businesses. The company also said it expects price increases to fully offset a larger inflation hit from rising oil prices, offering investors confidence that margins will remain protected despite elevated input costs.
MMM 
Deckers' Q1 Earnings Preview: Is DECK Ready to Surprise Wall Street?
Deckers heads into Q1 earnings results with strong HOKA and UGG momentum, but tariffs and higher investment spending may have pressured profitability.
DECK 
Here's Why AGC Inc. - Unsponsored ADR (ASGLY) Could be Great Choice for a Bottom Fisher
After losing some value lately, a hammer chart pattern has been formed for AGC Inc. - Unsponsored ADR (ASGLY), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
ASGLY 
Wall Street Analysts Predict a 121.36% Upside in Tenax Therapeutics (TENX): Here's What You Should Know
The mean of analysts' price targets for Tenax Therapeutics (TENX) points to a 121.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
TENX 
ABM Industries (ABM) Just Flashed Golden Cross Signal: Do You Buy?
ABM Industries Incorporated (ABM) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, ABM's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.
ABM 
Wall Street Analysts Predict a 35.12% Upside in Tyler Technologies (TYL): Here's What You Should Know
The consensus price target hints at a 35.1% upside potential for Tyler Technologies (TYL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
TYL 
Wall Street Analysts Think Arcutis Biotherapeutics (ARQT) Could Surge 25.79%: Read This Before Placing a Bet
The mean of analysts' price targets for Arcutis Biotherapeutics (ARQT) points to a 25.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
ARQT 
Wall Street Analysts See a 34.12% Upside in MakeMyTrip (MMYT): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 34.1% in MakeMyTrip (MMYT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
MMYT 
Wall Street Analysts Think Progress Software (PRGS) Could Surge 28.28%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 28.3% in Progress Software (PRGS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
PRGS 
Can Maze Therapeutics, Inc. (MAZE) Climb 120.48% to Reach the Level Wall Street Analysts Expect?
The consensus price target hints at a 120.5% upside potential for Maze Therapeutics, Inc. (MAZE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
MAZE 
Wall Street Analysts Think Mobileye (MBLY) Could Surge 46.93%: Read This Before Placing a Bet
The consensus price target hints at a 46.9% upside potential for Mobileye (MBLY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
MBLY 
Here's Why ams-OSRAM AG Unsponsored ADR (AMSSY) Is a Great 'Buy the Bottom' Stock Now
ams-OSRAM AG Unsponsored ADR (AMSSY) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
AMSSY 
Trump's 50% tariffs on Canada would include goods previously protected by the USMCA trade pact
President Donald Trump on Monday imposed 50% tariffs on most Canadian goods, declaring that Canada has unfairly discriminated against American autos, alcohol and dairy products.The move could unleash a new wave of economic chaos, with risks of higher inflation and further fraying of relations between two nations that had been closely woven together before Trump's return to the White House. The administration official previewing the action said that Canada was one of the only nations other than China that retaliated against Trump's previous tariffs and must be held accountable.The official insisted on anonymity on a call with reporters to preview the president's actions and said that Trump signed three proclamations to launch the tariffs under Section 338 of the 1930 Trade Act.
EWC 
Boston Scientific's Q2 Earnings Coming Up: Buy, Hold or Sell the Stock?
BSX faces Q2 results with growth expected in key businesses, but lowered full-year guidance, cost pressures and weak stock performance cloud the outlook.
BSX 
Block (XYZ) is a Top-Ranked Momentum Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
SQ 
Tokyo Electron: Favorable Read-Across From Industry Value Chain
Tokyo Electron Limited remains a 'Buy,' supported by robust client demand and positive trade flows. TOELY's near-term outlook is promising, given that its top-5 client TSMC has recently raised its CapEx guidance by a mid-teens percentage. Semiconductor production equipment exports in Tokyo Electron's home market, Japan, rose on a year-on-year basis for three consecutive months during the March-May '26 period.
TOELY 
